KUALA LUMPUR: Malaysia is gearing up to be a regional Hepatitis C treatment hub by offering a combination treatment of ravidasvir and sofosbuvir at affordable rates, says Khairy Jamaluddin.
The Health Minister said Malaysia was able to offer the drug combination as a new medical tourism product after it became the first country to be given conditional approval to provide the treatment.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
